Greenberg Traurig adds three shareholders from Weil

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greenberg Traurig adds three shareholders from Weil

A team of three patent litigation partners is leaving Weil Gotshal & Manges to join Greenberg Traurig’s Washington, DC office.

Mark Davis, Stephen Shahida and Ronald Pabis have agreed to join Greenberg Traurig as shareholders, although the exact date of the move has yet to be determined.

Davis, who focuses on IP rights and associated antitrust issues, will join the firm as chair of its International Trade Commission practice.

Pabis focuses on patent trials, licensing and other technology-related disputes. He also has experience in Section 337 investigations before the ITC.

Shahida focuses on patent disputes. Prior to joining Weil Gotshal, he co-headed the Washington, DC IP litigation practice at McDermott Will & Emery.



more from across site and SHARED ros bottom lb

More from across our site

With INTA 2026 just two months away, London-based IP practitioners offer tips on making the most out of the city
New platform, which covers SEPs for the Wi-Fi 6 and Wi-Fi 7 standards, includes 10 patent owners
The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Gift this article